INFONDRIAN received AN NIH STTR PHASE II AWARD
New York, NY (September 10, 2019) - Infondrian LLC is pleased to announce receiving a Small Business Technology Transfer (STTR) Phase II award from Department of Health and Human Services, National Institutes of Health. This two-year $1.7M grant will enable us to continue developing and clinically validating the next-generation automated treatment error detection software to improve patient safety, prevent treatment errors, reduce healthcare cost, and increase chart checking efficiency in radiation therapy.
INFONDRIAN RELEASES CHARTALERT 1.50 BETA
Coralville, IA (May 25, 2018) - After 17 months development and clinical validation, Infondrian today releases revolutionary ChartAlert 1.50 software for beta testing. University of Iowa Hospitals and Clinics and Great River Medical Systems are among the first institutions to receive this update. ChartAlert software automatically checks approximately 120 patient treatments on daily basis, significantly improving the efficiency of detecting treatment errors.
Infondrian received AN NIH STTR Phase I award
Coralville, IA (September 9, 2016) - Infondrian LLC, a University of Iowa spin-off, announced receiving a $225,000 Small Business Technology Transfer (STTR) Phase I award from Department of Health and Human Services, National Institutes of Health. This one year grant enables Infondrian to develop ChartAlert software for automated patient treatment chart checks in radiation therapy.
Infondrian received proof of commercial relevance award
Coralville, IA (October 7, 2015) - Infondrian LLC announced receiving a $25,000 Proof of Commercial Relevance Award from Iowa Economic Development Authority.